Tertiary cytoreduction for recurrence of ovarian CANCER patients after intraperitoneal chemotherapy

IntroductionThis study evaluated the feasibility, complications, and outcomes of a tertiary cytoreduction after second-line treatment with IP (intraperitoneal) versus IV (intravenous) chemotherapy in recurrent ovarian cancer (ROC) patients.MethodsWe retrospectively collected data of patients treated...

Full description

Bibliographic Details

Main Authors:	Giusi Santangelo, Enrico Ciminello, Tullio Golia d’Augè, Violante Di Donato, Federica Tomao, Innocenza Palaia, Margherita Fischetti, Giorgio Bogani, Ludovico Muzii, Pierluigi Benedetti Panici, Giorgia Perniola
Format:	Artigo
Language:	Inglês
Published:	Frontiers Media S.A. 2025-11-01
Series:	Frontiers in Medicine
Subjects:	recurrent ovarian cancer intraperitoneal chemotherapy intravenous chemotherapy tertiary cytoreduction adhesion score
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1691155/full
Tags:	Add Tag No Tags, Be the first to tag this record!